Table of Contents

2019-2024 Global Opioid-Induced Constipation Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioid-Induced Constipation Consumption 2014-2024
2.1.2 Opioid-Induced Constipation Consumption CAGR by Region
2.2 Opioid-Induced Constipation Segment by Type
2.2.1 Methylnaltrexone Bromide
2.2.2 Lubiprostone
2.2.3 Naloxegol
2.2.4 Others
2.3 Opioid-Induced Constipation Consumption by Type
2.3.1 Global Opioid-Induced Constipation Consumption Market Share by Type (2014-2019)
2.3.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2014-2019)
2.3.3 Global Opioid-Induced Constipation Sale Price by Type (2014-2019)
2.4 Opioid-Induced Constipation Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Opioid-Induced Constipation Consumption by Application
2.5.1 Global Opioid-Induced Constipation Consumption Market Share by Application (2014-2019)
2.5.2 Global Opioid-Induced Constipation Value and Market Share by Application (2014-2019)
2.5.3 Global Opioid-Induced Constipation Sale Price by Application (2014-2019)

3 Global Opioid-Induced Constipation by Players
3.1 Global Opioid-Induced Constipation Sales Market Share by Players
3.1.1 Global Opioid-Induced Constipation Sales by Players (2017-2019)
3.1.2 Global Opioid-Induced Constipation Sales Market Share by Players (2017-2019)
3.2 Global Opioid-Induced Constipation Revenue Market Share by Players
3.2.1 Global Opioid-Induced Constipation Revenue by Players (2017-2019)
3.2.2 Global Opioid-Induced Constipation Revenue Market Share by Players (2017-2019)
3.3 Global Opioid-Induced Constipation Sale Price by Players
3.4 Global Opioid-Induced Constipation Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Opioid-Induced Constipation Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Opioid-Induced Constipation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Opioid-Induced Constipation by Regions
4.1 Opioid-Induced Constipation by Regions
4.1.1 Global Opioid-Induced Constipation Consumption by Regions
4.1.2 Global Opioid-Induced Constipation Value by Regions
4.2 Americas Opioid-Induced Constipation Consumption Growth
4.3 APAC Opioid-Induced Constipation Consumption Growth
4.4 Europe Opioid-Induced Constipation Consumption Growth
4.5 Middle East & Africa Opioid-Induced Constipation Consumption Growth

5 Americas
5.1 Americas Opioid-Induced Constipation Consumption by Countries
5.1.1 Americas Opioid-Induced Constipation Consumption by Countries (2014-2019)
5.1.2 Americas Opioid-Induced Constipation Value by Countries (2014-2019)
5.2 Americas Opioid-Induced Constipation Consumption by Type
5.3 Americas Opioid-Induced Constipation Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Opioid-Induced Constipation Consumption by Countries
6.1.1 APAC Opioid-Induced Constipation Consumption by Countries (2014-2019)
6.1.2 APAC Opioid-Induced Constipation Value by Countries (2014-2019)
6.2 APAC Opioid-Induced Constipation Consumption by Type
6.3 APAC Opioid-Induced Constipation Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Opioid-Induced Constipation by Countries
7.1.1 Europe Opioid-Induced Constipation Consumption by Countries (2014-2019)
7.1.2 Europe Opioid-Induced Constipation Value by Countries (2014-2019)
7.2 Europe Opioid-Induced Constipation Consumption by Type
7.3 Europe Opioid-Induced Constipation Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Opioid-Induced Constipation by Countries
8.1.1 Middle East & Africa Opioid-Induced Constipation Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Opioid-Induced Constipation Value by Countries (2014-2019)
8.2 Middle East & Africa Opioid-Induced Constipation Consumption by Type
8.3 Middle East & Africa Opioid-Induced Constipation Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Opioid-Induced Constipation Distributors
10.3 Opioid-Induced Constipation Customer

11 Global Opioid-Induced Constipation Market Forecast
11.1 Global Opioid-Induced Constipation Consumption Forecast (2019-2024)
11.2 Global Opioid-Induced Constipation Forecast by Regions
11.2.1 Global Opioid-Induced Constipation Forecast by Regions (2019-2024)
11.2.2 Global Opioid-Induced Constipation Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Opioid-Induced Constipation Forecast by Type
11.8 Global Opioid-Induced Constipation Forecast by Application

12 Key Players Analysis
12.1 Takeda Pharmaceuticals
12.1.1 Company Details
12.1.2 Opioid-Induced Constipation Product Offered
12.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Takeda Pharmaceuticals News
12.2 Bayer
12.2.1 Company Details
12.2.2 Opioid-Induced Constipation Product Offered
12.2.3 Bayer Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bayer News
12.3 Sanofi
12.3.1 Company Details
12.3.2 Opioid-Induced Constipation Product Offered
12.3.3 Sanofi Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Sanofi News
12.4 Mallinckrodt
12.4.1 Company Details
12.4.2 Opioid-Induced Constipation Product Offered
12.4.3 Mallinckrodt Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Mallinckrodt News
12.5 Salix (Bausch Health)
12.5.1 Company Details
12.5.2 Opioid-Induced Constipation Product Offered
12.5.3 Salix (Bausch Health) Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Salix (Bausch Health) News
12.6 AstraZeneca
12.6.1 Company Details
12.6.2 Opioid-Induced Constipation Product Offered
12.6.3 AstraZeneca Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 AstraZeneca News
12.7 Progenics Pharmaceuticals
12.7.1 Company Details
12.7.2 Opioid-Induced Constipation Product Offered
12.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Progenics Pharmaceuticals News
12.8 Purdue Pharm
12.8.1 Company Details
12.8.2 Opioid-Induced Constipation Product Offered
12.8.3 Purdue Pharm Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Purdue Pharm News
12.9 Nektar Therapeutics
12.9.1 Company Details
12.9.2 Opioid-Induced Constipation Product Offered
12.9.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Nektar Therapeutics News
12.10 Daiichi Sankyo
12.10.1 Company Details
12.10.2 Opioid-Induced Constipation Product Offered
12.10.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Daiichi Sankyo News
12.11 Prestige
12.12 GSK
12.13 Shionogi

13 Research Findings and Conclusion